Indonesia pharmaceutical market segment (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region), competitive landscape of major players in the Indonesia pharmaceutical market covering company profile of PT Kalbe Farma, PT Sanbe Farma, PT SOHO Global Health, PT Dexa Medica, PT Pharos, PT Kimia Farma, PT Tempo Scan Pacific Tbk, PT Merck Tbk, Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma, Darya Varia and Konimex. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.
Majority pharmaceutical companies are located in West Java and Jakarta due to favorable tax incentives, well developed infrastructure and greater access to medicinal herbs.
Healthcare industry in Indonesia is driven by the surging number of hospitals, clinics and pharmacy stores coupled with rising prevalence of chronic diseases including diabetes, HIV, Tuberculosis and others. It is anticipated that over 35,000 new beds will be added in Indonesia by 2020. Indonesia is anticipated to achieve 1.5 beds per 1,000 people by 2019 with the entry of new private hospitals and increased capacity of existing ones.
The pharmaceutical sector will observe a rise in demand for nutrition and vitamin and dietary supplements. Pharmaceutical companies are anticipated to shift focus to other niche segments including combined dosages, novel drug delivery areas besides manufacturing generic and patented drugs. Indonesia pharmaceutical market is anticipated to grow in future with surging ageing population, increased health care spending and rise in lifestyle related diseases.
The distribution channel will be dominated by hospital and clinics which implies a shift from physicians and pharmacies. So the companies now need to target the hospitals and clinics more in their marketing activities. The industry will witness an increased investment from foreign players and the prevalence of chronic diseases such as cancer, HIV and others will lead to increase demand for innovative products particularly in the field of biopharmaceuticals. With the increase in role of government in the Indonesian healthcare industry, the pharmaceutical companies need to look for government tenders as government opts for e-procurement methods to procure medicines for various public and private hospitals participating in the universal healthcare system
Emerging Contract Development and Manufacturing Organizations market, increasing number of mergers & acquisitions coupled with elevating prevalence of chronic and lifestyle diseases will propel the Indonesia pharmaceutical market revenue in future.
Ken Research in its latest study, “Indonesia Pharmaceutical Market Outlook to 2022 – By Therapeutic Segment (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology), By Domestic and International Players, By Generic and Patent Drugs, By OTC & Prescription Drugs, By Region”, suggests that demand for pharmaceutical products in the market will continue to grow in Indonesia owing to favorable government regulations for FDI inflows and growing vitamin and dietary supplements market.
Key Topics Covered in the Report:
Pharmaceutical Market Size Indonesia
Kalbe Farma Competitors Indonesia
Healthcare Spending Indonesia
Obese Population Indonesia
Indonesia Healthcare Market Future
Animal Pharmaceutical Market Indonesia
Biopharmaceutical Market Indonesia
Indonesia Vaccine Market
Generic Drug Market Size Indonesia
Market Share of Major Players in Indonesia Pharmaceutical Market
Vitamin and Dietary Supplement Market Indonesia
Major Therapeutic Segment in Indonesia Pharmaceutical Market
Type of Generic Drugs in Indonesia
Mergers & Acquisitions in Indonesia Pharmaceutical Market
Pharmaceutical Market Exports Indonesia
Pharmaceutical Market Future Trends Indonesia
Number of Pharmaceutical Companies Indonesia
Trends Indonesia Pharmaceutical Market
Issues & Challenges in Indonesia Pharmaceutical Market
Government Regulations in Indonesia Pharmaceutical Market
Number of Healthcare Centers in Indonesia
Budget Allocation on Healthcare Indonesia
Major Companies Pharmaceutical Market Indonesia
For more information on the research report, refer to below link:
Related Reports by Ken Research
https://www.kenresearch.com/healthcare/general-healthcare/uae-healthcare-market-report/37505-91.html
Contact:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204
